Some studies showed that the recurrent NAB2-STAT6 gene fusion and STAT6 immunohistochemical expression are present in almost all cases, the last one being especially helpful in identifying CD34-negative solitary fibrous tumors [4,6,11,15,16,25,33]. The gene discussed is CD34; the disease is solitary fibrous tumor.